Candida auris: Epidemiology and Antifungal Strategy

被引:1
|
作者
Eix, Emily F.
Nett, Jeniel E. [1 ]
机构
[1] Univ Wisconsin Madison, Dept Med, Madison, WI 53706 USA
来源
ANNUAL REVIEW OF MEDICINE | 2025年 / 76卷
关键词
Candida auris; epidemiology; treatment; drug resistance; transmission; antifungal; microbiome; skin colonization; UNITED-STATES; NEW-YORK; CLONAL STRAIN; IN-VITRO; RESISTANT; INFECTIONS; OUTBREAK; DISINFECTANTS; MANAGEMENT; FUNGEMIA;
D O I
10.1146/annurev-med-061523-021233
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Candida auris is a recently emerged fungal pathogen that causes severe infections in healthcare settings around the globe. A feature that distinguishes C. auris from other fungal pathogens is its high capacity to colonize skin, leading to widespread outbreaks in healthcare facilities via patient-to-patient transmission. C. auris can persist on skin or in the surrounding environment for extended periods of time, and it exhibits greater antifungal resistance than other Candida species. These factors pose major obstacles for the prevention and treatment of C. auris infection. Recent reports have identified frequently colonized skin sites, risk factors for developing invasive infection, and patterns of antifungal resistance among C. auris strains, all of which help guide therapeutic options. In this review, we highlight key studies of C. auris epidemiology and antifungal resistance, discussing how these factors influence healthcare-associated transmission and treatment outcomes.
引用
收藏
页码:57 / 67
页数:11
相关论文
共 50 条
  • [41] Collateral sensitivity counteracts the evolution of antifungal drug resistance in Candida auris
    Carolus, Hans
    Sofras, Dimitrios
    Boccarella, Giorgio
    Jacobs, Stef
    Biriukov, Vladislav
    Goossens, Louise
    Chen, Alicia
    Vantyghem, Ina
    Verbeeck, Tibo
    Pierson, Siebe
    Romero, Celia Lobo
    Steenackers, Hans
    Lagrou, Katrien
    van den Berg, Pieter
    Berman, Judith
    Gabaldon, Toni
    Van Dijck, Patrick
    NATURE MICROBIOLOGY, 2024, 9 (11): : 2954 - 2969
  • [42] Recent Antifungal Pipeline Developments against Candida auris: A Systematic Review
    Trevino-Rangel, Rogelio De J.
    Gonzalez, Gloria M.
    Montoya, Alexandra M.
    Rojas, Olga C.
    Elizondo-Zertuche, Mariana
    Alvarez-Villalobos, Neri A.
    JOURNAL OF FUNGI, 2022, 8 (11)
  • [43] Antifungal drug susceptibility of Candida auris isolates from German hospitals
    Martin, R.
    Ebner, S.
    Hamprecht, A.
    Walther, G.
    Wagener, J.
    Kurzai, O.
    MYCOSES, 2018, 61 : 34 - 35
  • [44] Antifungal activity of human antimicrobial peptides targeting apoptosis in Candida auris
    Shaban, Siham
    Patel, Mrudula
    Ahmad, Aijaz
    JOURNAL OF MEDICAL MICROBIOLOGY, 2024, 73 (05)
  • [45] Comparative genomics and antifungal susceptibility testing of clinical Candida auris isolates
    Herz, M.
    Barber, A. E.
    Ebner, S.
    Aldejohann, A. M.
    Walther, G.
    Martin, R.
    Kurzai, O.
    MYCOSES, 2021, 64 : 18 - 18
  • [46] Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris
    Kean, Ryan
    Ramage, Gordon
    MSPHERE, 2019, 4 (04)
  • [47] Candida auris
    Schwartz, Ilan S.
    Dingle, Tanis C.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (31) : E865 - E865
  • [48] Candida auris
    Saris, Katja
    Meis, Jacques F.
    Voss, Andreas
    CURRENT OPINION IN INFECTIOUS DISEASES, 2018, 31 (04) : 334 - 340
  • [49] Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options
    Orlandi Sardi, Janaina de Cassia
    Silva, Diego Romario
    Soares Mendes-Giannini, Maria Jose
    Rosalen, Pedro Luiz
    MICROBIAL PATHOGENESIS, 2018, 125 : 116 - 121
  • [50] Importation, Mitigation, and Genomic Epidemiology of Candida auris at a Large Teaching Hospital
    Lesho, Emil P.
    Bronstein, Melissa Z.
    McGann, Patrick
    Stam, Jason
    Kwak, Yoon
    Maybank, Rosslyn
    McNamara, Jodi
    Callahan, Megan
    Campbell, Jean
    Hinkle, Mary K.
    Walsh, Edward E.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2018, 39 (01): : 53 - 57